- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04907045
An Initial Study of the Implementation of Digital Therapeutics for Substance Use Disorders in Primary Care (DIGITS Pilot)
April 1, 2024 updated by: Kaiser Permanente
Digital Therapeutics for Opioids and Other Substance Use Disorders in Primary Care Pilot (DIGITS Trial Pilot)
The DIGITS Trial addresses a critical knowledge gap: How to best implement digital treatments for opioids and other substance use disorders in primary care.
In this pilot study, the FDA-authorized reSET and reSET-O digital therapeutics will be implemented in 2 primary care clinics as part of quality improvement.
The study will test and refine the two experimental implementation strategy interventions, health coaching (patient-facing) and practice coaching (clinician-facing).
This study will also pilot economic data collection tools and collect qualitative data for a formative evaluation.
The analytic goals are to inform the statistical design and data collection processes for the subsequent cluster-randomized DIGITS Trial.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
700
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Joseph E Glass, PhD, MSW
- Phone Number: 206-287-4266
- Email: joseph.e.glass@kp.org
Study Contact Backup
- Name: Tara C Beatty, MA
- Phone Number: 206-442-4012
- Email: tara.c.beatty@kp.org
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98101
- Kaiser Permanente Washington
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Had a primary care visit in a participating clinic during the pilot
- Screened positive for substance use
- Adult aged 18 years or older at time of visit
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Standard Implementation Plus Health Coaching
The clinic in this arm will implement reSET and reSET-O with a standard implementation strategy and patients at the clinic will receive support from a health coach to help them engage with reSET and reSET-O.
|
The clinic is provided access to a health coach who conducts outreach with patients.
The health coach facilitates engagement with the digital therapeutic and encourages contact with the care team.
Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.
|
Experimental: Standard Implementation Plus Health Coaching and Practice Facilitation
The clinic in this arm will implement reSET and reSET-O with a standard implementation strategy and patients at the clinic will receive support from a health coach to help them engage with reSET and reSET-O.
Additionally, a practice facilitator will provide the clinic with support for implementation.
|
The clinic is provided access to a health coach who conducts outreach with patients.
The health coach facilitates engagement with the digital therapeutic and encourages contact with the care team.
Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.
In the context of a supportive relationship, a trained facilitator delivers the following interventions to clinic staff: Bolster Education, Audit and Provide Feedback, Support Plan-Do-Study-Act Cycles, Engage Others in Change.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reach of the digital therapeutic to patients in the primary care clinic
Time Frame: 3 months
|
The proportion of patients who initiate the digital therapeutic, defined by instances in which patients open the app, enter the prescription code, and use a treatment module
|
3 months
|
Fidelity of patients use of the digital therapeutic to clinical recommendations
Time Frame: 6 months
|
Mean number of weeks in which patients use 4 app modules/week and have visited a clinician in the past month
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effectiveness
Time Frame: 6 months
|
Mean number of months in which patients make monthly visits for substance use disorder
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reach-2
Time Frame: 3 months
|
The proportion of patients prescribed reSET or reSET-O
|
3 months
|
Reach-3
Time Frame: 3 months
|
The proportion of patients who download and unlock reSET or reSET-O
|
3 months
|
Fidelity-2
Time Frame: 6 months
|
Mean number of weeks in which patients use at least 1 module/week
|
6 months
|
Fidelity-3
Time Frame: 6 months
|
Mean number of weeks in which patients use at least 4 modules/week
|
6 months
|
Adoption
Time Frame: 3 months
|
The proportion of other healthcare providers initiating a patient on reSET or reSET-O, overall and by provider type
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Joseph E Glass, PhD, MSW, Kaiser Permanente
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 6, 2021
Primary Completion (Actual)
April 29, 2022
Study Completion (Estimated)
July 9, 2024
Study Registration Dates
First Submitted
May 25, 2021
First Submitted That Met QC Criteria
May 25, 2021
First Posted (Actual)
May 28, 2021
Study Record Updates
Last Update Posted (Actual)
April 2, 2024
Last Update Submitted That Met QC Criteria
April 1, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 218046
- R01DA047954 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol-Related Disorders
-
National Institute on Alcohol Abuse and Alcoholism...AbbVieCompletedAlcohol Dependence | Alcoholism | Alcohol Use Disorders | Alcohol AbuseUnited States
-
Charles Drew University of Medicine and ScienceWithdrawnAlcohol Drinking | Alcohol Use Disorder | Alcohol Abuse | Alcohol Problem
-
University of New MexicoThe Mind Research NetworkActive, not recruitingAlcohol Drinking | Alcohol Dependence | Alcohol Use Disorder | Alcohol AbuseUnited States
-
Kent State UniversityCompletedAlcohol Use Disorder | Alcohol Abuse | Alcohol Abuse, EpisodicUnited States
-
Karolinska InstitutetCompletedAlcohol Drinking | Alcohol Dependence | Alcohol; Harmful Use | Alcohol Use Disorder | Alcohol AbuseSweden
-
University of Colorado, DenverUnknownAlcohol Use Disorders | Unhealthy Alcohol UseUnited States
-
Boston Medical CenterBoston University; National Institute on Alcohol Abuse and Alcoholism (NIAAA); University of PittsburghCompletedAlcohol Dependence | Alcohol ConsumptionUnited States
-
Boston Medical CenterBoston University; National Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol Dependence | Alcohol Abuse | Unhealthy Alcohol Use | Risky Alcohol Consumption Amounts | Hazardous Alcohol UseUnited States
-
National Institute on Alcohol Abuse and Alcoholism...CompletedAlcohol Drinking | Alcoholism | Alcohol Abuse | Alcohol-related DisordersUnited States
-
Queen Mary University of LondonBarts & The London NHS Trust; University of HertfordshireRecruitingAlcohol Use Disorder | Alcohol Abuse or DependenceUnited Kingdom
Clinical Trials on Health Coaching
-
Habit DesignUniversity of Washington; TriHealth Inc.Recruiting
-
University of California, San FranciscoKaiser PermanenteCompleted
-
Kansas State UniversityUnknown
-
Pack HealthGlaxoSmithKline; University of WashingtonRecruitingMultiple Myeloma | Relapsed Hematologic MalignancyUnited States
-
York UniversityTerminated
-
Thomas Jefferson UniversityAmerican Occupational Therapy FoundationRecruitingStroke, Acute | Caregiver Stress Syndrome | Caregiver BurnoutUnited States
-
Food and Health Bureau, Hong KongRecruiting
-
Chinese University of Hong KongRecruitingCardiovascular Diseases | Metabolic Diseases | CoachingHong Kong
-
Indonesia UniversityCompletedThe Effectiveness of "CARE Coaching Model" as an Effort to Empower Type 2 Diabetes Mellitus PatientsDiabetes Type 2Indonesia
-
University of California, Los AngelesCompletedHypertension | Obesity | Sedentary Lifestyle | PreDiabetes | Lifestyle-related ConditionUnited States